Skip to content
  • Home
  • What We Do
    • What We Do
    • Treaty
      • Accident & Health
      • Agriculture / Crop
      • Aviation & Marine
      • Cyber
      • Energy
      • Engineering
      • Entertainment & Contingency
      • Financial Guaranty
      • Traditional Casualty
      • Management & Professional Liability
      • Medical Professional Liability
      • Mortgage Indemnity
      • Property
      • Surety, Trade Credit & Political Risk
      • Terrorism
    • Facultative
    • TransRe Applied Data
    • Insurtech Partners
    • Mortgage Partners
    • Blue Marble Microinsurance
  • About Us
    • About us
    • History
    • Leadership
    • Financial Information
    • Press Releases
    • Social Conscience
      • Social Conscience
      • Global Volunteerism
      • National Coastal Resilience Fund
  • Contact Us
    • Office Locations
    • Regional Business Units
    • Global Portfolio Management
  • Insights
  • Events
  • Legal
  • Careers
menu

Close
  • Home
  • What We Do
    • Lines Of Business
      • Lines of Business
      • TREATY
        • Accident & Health
        • Agriculture / Crop
        • Aviation & Marine
        • Cyber
        • Energy
        • Engineering
        • Entertainment & Contingency
        • Financial Guaranty
        • Traditional Casualty
        • Management & Professional Liability
        • Medical Professional Liability
        • Mortgage Indemnity
        • Property
        • Surety, Trade Credit & Political Risk
        • Terrorism
      • FACULTATIVE
        • Engineering
        • Entertainment & Contingency
        • Management & Professional Liability
        • Medical Professional Liability
        • Property
        • Traditional Casualty
    • TransRe Applied Data
    • Insurtech Partners
    • Mortgage Partners
    • Blue Marble Microinsurance
  • About us
    • About Us
    • History
    • Leadership
    • Financials
      • Financial Highlights
      • Financial Highlights: Tokyo
      • Ratings
      • FATCA Compliance
      • Solvency and Financial Condition Reports
    • Press Releases
    • Social Conscience
      • Social Conscience
      • Research & Resilience
      • Global Volunteerism
      • National Coastal Resilience Fund
  • Contact Us
    • Office Locations
    • Regional Business Units
    • Global Portfolio Management
  • Insights
  • Events
  • Legal
  • Careers
Download PDF

U.S. Public D&O Insurance

2026 Market Update

Losses are being driven by the severity of mega/large cap claims.

2023 is showing early signs of deterioration, although it is too soon to say whether that will continue, and whether 2024 and 2025 will follow.

Against a backdrop of rising losses, pricing sentiment remains strangely complacent, especially for mid-excess layers, the market segment that appears most vulnerable.

April 2026

Share
(5 Minute Read)

Share this page





‘Fighting for flat’ was last year’s less-than-inspiring rallying cry. As losses continue to pile up, we need a new slogan before this cycle of D&O underwriting is remembered as the time when we forgot what profit looks like. 

We start with the fundamentals, and nothing is more fundamental than losses.

Section 1: Loss Drivers

Cornerstone Research tracks Securities Class Action activity, and we track their data.

Frequency

Although 2025’s overall frequency was lower than 2023/2024 and (just) below the long term average, we have already seen 65 filings (260 annualized) in the first quarter of 2026:

Legal Filings For “Core” (ex merger objection) Claims, 2013-2025

Source: Cornerstone Research

Large ($10-$100B) and Mega ($100B+) cap companies almost always exceed the overall filing frequency:

SCA Filings By Market Capitalization, 2015-2025

Source: SSLA, Factset, TransRe

Severity

Adopting Cornerstone’s DDL (Disclosure Dollar Loss =  the dollar-value change in the defendant firm’s market capitalization between the trading day immediately preceding the end of the class period and the trading day immediately following the end of the class period). MDL (Maximum Dollar Loss = the dollar-value change in the defendant firm’s market capitalization from the trading day with the highest market cap during the class period to the trading day immediately following the end of the class period) methodology, adjusted to 2025 dollars, we note:

In 2025 mega caps delivered the highest ever DDL ($694B vs $429B in 2024) and the third highest ever MDL. Mega cap filings also represented a higher share of total DDL and MDL than the long term (1997-2024) average:

Mega Cap Average Maximum Dollar Loss, 2015-2025

Source: SSLA, FactSet, TransRe

Although large caps saw some (temporary) relief in 2025, both mega and large caps show the same general upward trend: 

Large Cap Average Maximum Dollar Loss, 2015-2025

Source: SSLA, FactSet, TransRe

A quick look at median settlements, split by market cap, tells a similar story, mega cap outcomes are also driving severity as much as frequency:

SCA Case Outcomes By Median Settlement $M, 2015-2025 Filing Years


Source: SSLA, FactSet, TransRe

Inflation

Although less discussed than ‘social’ inflation, the 44% cumulative rise in legal fees since 2020 impacts the cost of defending claims, and increasingly eats through working layers and exacerbates excess layer severity. The longer a case survives, the higher the costs (discovery/legal fees) and the greater the fear of a catastrophic/nuclear outcome. This may lead to defendants settling cases that they should otherwise defend.

Legal Services Fee Inflation, 2013-2026

Source: Bureau of Labor Statistics, St Louis Fed (FRED)

Individual outcomes may be difficult to predict, but the overall frequency and severity indicators are clear.

Section 2: Loss Ratios

In our actuarial analysis, we assume 70% is the market breakeven loss ratio, after 15% acquisition costs and 15% internal expenses. We calculate margin dollars are GWP* (70% – expected ULR).

Clearly the low losses and price gains in 2021/2022 helped generate strong expected results. However the combination of recent losses, legal cost inflation and exposure growth is fast eroding that ‘bank’:

Commercial D&O Expected ULRs/Margin, 2014-2026(Projected)


Source: TransRe

Widening our view to industry-wide loss ratios (Other Liability Claims Made in Schedule P) we compared first picks against latest. The 2016/19 years are bad and getting worse, 2020/22 are good and getting better, but 2023 is already ringing alarm bells and further deterioration is a real possibility – OLCM includes Cyber and Transactional Liability, which have seen early development. Although 2024 and 2025 are too new to officially call, recent pricing provides little comfort.

Schedule P – Other Liability Claims Made Ultimate Loss Ratios, Initial vs Latest (as at 12/25)


Source: Schedule P

Section 3: Prices

Loss ratios are a function of prices as well as losses. Having reviewed the evidence of frequency, severity and legal inflation, rational observers might expect prices to have risen. Said observers would be disappointed.

Overall, prices have stopped dropping, yet the low/mid-excess layers remain under the most pressure, despite being vulnerable to any increase in severity. Insurers have targeted these lower excess layers via drop-down strategies in recent years, and we wonder if ILFs here are now the weakest in the tower?

TransRe U.S. Public D&O Insurance Price Index (All Policies) By Attachment Point, 2013-2025


Source: TransRe (index excludes IPO/SPAC data to highlight more general trends).

Mega and large cap prices have levelled off, but are now -13 and -17% off their peak respectively. These companies have the highest frequency and severity yet the chart below shows they have garnered the least amount of price since 2013, despite the dramatic rise in market caps and therefore growth in exposure.

TransRe U.S. Public D&O Insurance Commercial Price Index, By Insured Market Cap, 2013-2025


Source: TransRe

Although more policies are renewing flat, those renewing down did so at an average of -10% in 2025, and too few have achieved price increases since the end of 2021.

Price Outcomes Of Renewing Commercial Policies Since 2018


Source: TransRe

The Bottom Line

Last year we noted the race to give back profits before they are fully earned, and we take little pleasure in the mounting evidence that severity is trending upward, but prices are only flattening, which (in our opinion) is not enough to weather the challenges ahead.

Overall SCA frequency appears to have reverted to the long-term average, but not for Mega and Large cap defendants. We are also seeing alarming indicators of potential severity and our ‘risk off’ position is unchanged.

An excess of capacity, an ongoing desire by many carriers to reposition lower in towers and a reluctance to vigorously defend claims combine to weaken insurers’ pricing power at a time when external dynamics (geopolitical volatility, legal inflation) point to the need for significant rate rises. 

The path to profitability seems clear.

About Our Database, Methodology & Sources

Over decades (and billions of premiums and corresponding claim payments) we have accumulated significant management and professional liability data and insights. We supplement this with licensed third party data and publicly available information, combined into our proprietary analytics engine. Our database includes details of 30,000+ policies.

We separate out Financial Institutions and sub-divide Commercial by company size and attachment point:

 

We focus on price rather than rate, to exclude (untrackable) changes in coverage.

In addition to general inflation (CPI) and Legal Services inflation (LSI)we monitor underlying loss cost trend (not just defense costs) which reflects increased severity as the plaintiffs’ bar pursues fewer but more likely cases and asks for more.

Sources

We only include the business we see. While we believe this to be a majority of what is available, it is not the entire market. In addition to publicly available data and our own insights, we use third-party data from a combination of FactSet, Stanford Securities Litigation Analytics, Stanford Law School Securities Class Action Clearinghouse, The D&O Diary, SNL and National Economic Research Associates (NERA), whose work we gratefully acknowledge. To maintain our claims database, we actively monitor major suits and their outcomes.

Contacts

To discuss any aspect of this report, or your ongoing U.S. Public D&O reinsurance needs, please reach out to any member of the production team:

Portfolio Management

Elise McKenzie

Anthony Matteo

Ben Casey

Geet Shah

Underwriting

Daniel Hojnowski

Alexa Cosenza

George Delaney

William Seymour

Mathew Yuen

Dierdre Zeppie

Lonny Agulnick (Fac)

Actuarial

Joe Marracello

Kevin Peterson

Claims

Seth Goldberg

You can also reach us at communications@transre.com.

Legal

Reproduction in any form without permission of TransRe is prohibited.

The material and conclusions contained in this document are for information purposes only and TransRe offers no guarantee for the completeness of its contents. 

Statements in this document may provide current expectations of future events based on certain assumptions. These statements involve known and unknown risks, uncertainties and other factors which are not exhaustive. Although TransRe makes reasonable efforts to obtain information from reliable sources, TransRe does not guarantee the accuracy or completeness of the information given or any forward-looking statements made. 

TransRe undertakes no obligations to revise or update any statements, whether as a result of new information, future events or otherwise, and in no event shall TransRe or any of its affiliates or employees be liable for any damage or loss arising in connection with the use of the information relating to this document.

Appendix 1: Significant Settlements Since 2013

(Bold = Derivative)

 

2013 Activision Blizzard, Inc.
Barrick Gold Corporation
Blackberry Limited
DFC Global Corp
Dole Food Company, Inc.
Intuitive Surgical, Inc.
J.C. Penney Company, Inc.
Lumber Liquidators Holdings, Inc.
Medtronic plc
Onyx Pharmaceuticals, Inc.
Poseidon Concepts Corp.
2014 Advanced Micro Devices, Inc.
Altisource Portfolio Solutions SA
American Realty Capital Properties, Inc. n/k/a VEREIT, Inc.
Barclays PLC
Cliffs Natural Resources, Inc.
Cobalt International Energy Inc
General Motors Company
Genworth Financial, Inc.
GT Advanced Technologies, Inc.
Intercept Pharmaceuticals, Inc.
L-3 Communications Holdings, Inc.
Magnachip Semiconductor Corp.
NII Holdings, Inc.
Nu Skin Enterprises
Och-Ziff Capital Management Group LLC
Ocwen Financial Corporation
Petroleo Brasileiro SA – Petrobas
Ply Gem Holdings, Inc.
Rayonier, Inc.
RCS Capital Corporation
Salix Pharmaceuticals Ltd
Santander Consumer USA Holdings, Inc.
SeaWorld Entertainment, Inc.
Valeant Pharmaceutical International Inc. n/k/a Bausch Health Companies
2015 3D Systems Corporation
Alibaba Group Holding Limited
American Realty Capital Properties Inc. (n/k/a VEREIT, Inc.)
Charter Communications, Inc.
Chemical & Mining Company of Chile, Inc. (SQM)
Clovis Oncology, Inc.
Dole Food Company, Inc.
Good Technology, Inc.
Marvell Technology Group, Ltd.
Miller Energy Resources, Inc
Puma Biotechnology, Inc.
Rite Aid Corporation
SanDisk Corporation
Sears Holdings Corporation
Silver Wheaton Corporation
Stellantis NV (f/k/a Fiat Chrysler Automobiles NV)
SunEdison, Inc.
TerraForm Global, Inc.
Valeant Pharmaceutical International Inc. n/k/a Bausch Health Companies
Volkswagen AG
Volkswagen AG
Walgreen Company
2016 Adeptus Health, Inc.
Alexion Pharmaceuticals, Inc
Allergan plc f/k/a Actavis plc
American Capital Agency Corp.
BHP Billiton Limited
Brixmor Property Group, Inc.
Cnova N.V.
Cognizant Technology Solutions Corporation
comScore, Inc.
CoreCivic, Inc. f/k/a Corrections Corporation of America
DeVry, Inc.
Facebook, Inc.
Fitbit Inc.
HeartWare International, Inc.
IMPAX Laboratories, Inc.
Insys Therapeutics, Inc.
LendingClub Corporation
Lions Gate Entertainment Corp.
Navient Corporation
Orbital ATK, Inc
Patriot National, Inc.
Perrigo Company plc.
Signet Jewelers Limited
Stericycle, Inc.
Sunrun, Inc.
Taro Pharmaceutical Industries, Ltd.
Tesla, Inc.
Teva Pharmaceutical Industries Limited
The Allstate Corporation
The Fresh Market
TreeHouse Foods, Inc.
Twitter, Inc.
Twitter, Inc.
Wells Fargo & Company
Wells Fargo & Company
Zimmer Biomet Holdings, Inc
2017 Arconic Corporation f/k/a Arconic, Inc.
Calamos Asset Management, Inc.
Chicago Bridge & Iron Co. NV
DaVita, Inc.
DaVita, Inc.
Endo International plc
Envision Healthcare Corporation
Equifax, Inc.
Equifax, Inc.
FleetCor Technologies, Inc.
General Electric Company
Harman International Industries, Inc.
HD Supply Holdings, Inc.
Lumen Technologies, Inc. (f/k/a CenturyLink, Inc.)
Mallinckrodt plc
McKesson Corporation
Novo Nordisk A/S
Omega Healthcare Investors, Inc.
Ophthotech Corporation (n/k/a IVERIC Bio, Inc.)
Pacific Gas & Electric Corporation
Qualcomm, Inc.
RH, Inc.
SCANA Corporation
SCANA Corporation
Snap, Inc.
Tableau Software, Inc.
The Southern Company
Towers Watson & Co.
Twenty-First Century Fox, Inc.
Under Armour, Inc.
United States Steel Corporation
Yahoo! Inc.
Yahoo!, Inc.
2018 Acadia Healthcare Company, Inc.
ADT, Inc.
Advance Auto Parts, Inc.
Aegean Marine Petroleum Network, Inc.
Akorn, Inc.
Alphabet, Inc. f/k/a Google, Inc.
AmTrust Financial Services, Inc.
Bank OZK
BRF S.A.
Celgene Corporation
Columbia Pipeline Group, Inc.
Dentsply Sirona, Inc.
Diamond Resorts International, Inc.
Fluor Corporation
GreenSky, Inc.
Grupo Televisa, S.A.B.
Henry Schein, Inc.
Immunomedics, Inc.
Longfin Corp.
McKesson Corporation
Micro Focus International plc
Newell Brands, Inc.
Nielsen Holdings plc
Nissan Motor Co., Ltd.
NortonLifeLock Inc. f/k/a Symantec Corporation
Pacific Gas & Electric Corporation
Patterson Companies, Inc.
Pilgrim’s Pride
Renren, Inc. (n/k/a Moatable, Inc.)
Synchrony Financial
TrueCar, Inc.
WageWorks, Inc.
Wells Fargo & Company
Wells Fargo & Company
Windstream Holdings, Inc.
Wynn Resorts Limited
Wynn Resorts Limited
2019 2U, Inc.
Alphabet, Inc.
Altria Group, Inc.
Apple Computer, Inc.
Blackhawk Network Holdings, Inc.
CannTrust Holdings, Inc.
CannTrust Holdings, Inc.
Carbonite, Inc.
Cardinal Health, Inc.
Cardinal Health, Inc.
Conduent, Inc.
Coty, Inc.
Covetrus, Inc.
EQT Corporation
Exelon Corporation
Granite Construction, Inc.
Green Dot Corporation
Grubhub, Inc.
Kraft Heinz Company
Mallinckrodt plc
Mattel, Inc.
Maxar Technologies, Inc.
Mindbody, Inc.
Myriad Genetics, Inc.
Nutanix, Inc.
Pattern Energy Group, Inc
Perrigo Company plc.
Plantronics, Inc.
ProPetro Holding Corp.
Prudential Financial, Inc.
Qihoo 360 Technology Co. Ltd.
Resideo Technologies, Inc.
Silver Run Acquisition Corporation II
Spectrum Brands Holdings, Inc.
Stamps.com, Inc.
Stamps.com, Inc.
The Boeing Company
The Goldman Sachs Group, Inc.
Uber Technologies, Inc.
Uniti Group, Inc. f/k/a Communications Sales & Leasing, Inc.
Viacom, Inc. (Merger with CBS Corporation)
Zuora, Inc.
2020 Aimmune Therapeutics, Inc.
Akazoo S.A. f/k/a Modern Media Acquisition Corp.
Alibaba Group Holding Limited
Altria Group, Inc.
AmerisourceBergen Corp.
Bayer Aktiengesellschaft [Bayer AG]
Becton, Dickinson and Company
BioMarin Pharmaceutical, Inc.
Boston Scientific Corporation
CBS Corporation
Coterra Energy Inc. (f/k/a Cabot Oil & Gas Corporation)
Deutsche Bank AG
FirstEnergy Corporation
Forescout Technologies, Inc.
GoHealth, Inc.
Grand Canyon Education, Inc.
HP, Inc.
Inovio Pharmaceuticals, Inc.
JELD-WEN Holding, Inc.
L Brands, Inc.
Luckin Coffee, Inc.
Match Group, Inc.
Mohawk Industries, Inc.
Mylan, NV
Pattern Energy Group, Inc.
Pinterest, Inc.
Pivotal Software, Inc.
ProAssurance Corporation
Ryder System, Inc.
Six Flags Entertainment Corporation
Splunk, Inc.
Tesla, Inc.
Tilray, Inc.
Turquoise Hill Resources Ltd.
VMware, Inc.
Wells Fargo & Company
World Wrestling Entertainment, Inc.
Zoom Video Communications, Inc.
Zuora, Inc.
2021 AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp.
Alphabet, Inc. f/k/a Google, Inc. (Antitrust)
Apache Corporation
Chegg, Inc.
ChemoCentryx, Inc.
Credit Suisse Group
DiDi Global Inc. f/k/a Xiaoju Kuaizhi Inc.
Emergent Biosolutions, Inc.
Emisphere Technologies, Inc.
FibroGen, Inc.
InnovAge Holding, Inc.
James River Group Holdings, Ltd.
Madison Square Garden Entertainment Corp.
MSG Networks, Inc.
MultiPlan Corporation f/k/a Churchill Capital Corp. III
Novavax, Inc.
Nutanix, Inc.
QAD, Inc.
QuantumScape Corporation (f/k/a Kensington Capital Acquisition Corp.)
Reata Pharmaceuticals, Inc.
Romeo Power Inc. f/k/a RMG Acquisition Corp.
Sirius XM Holdings Inc.
Snap, Inc.
SolarWinds Corporation
StoneCo Ltd.
The Honest Company, Inc.
Velodyne LiDAR, Inc. f/k/a Graf Industrial Corp
ViacomCBS Inc.
Walmart, Inc.
Workhorse Group, Inc.
Zymergen, Inc.
2022 Cerence, Inc.
Compass Minerals International, Inc.
CreateAI Holdings Inc. (f/k/a TuSimple Holdings, Inc.)
GAIN Capital Holdings, Inc.
Getty Images Holdings, Inc.
Grab Holdings Limited f/k/a Altimeter Growth Corporation
Guess?, Inc.
LifeStance Health Group, Inc.
Newmark Group, Inc.
Oak Street Health, Inc.
Okta, Inc.
Olaplex Holdings, Inc.
Opendoor Technologies, Inc.
Pegasystems, Inc.
Premier, Inc.
Rivian Automotive, Inc.
Santander Consumer USA Holdings, Inc.
Sea Limited
Silvergate Capital Corporation
Stitch Fix, Inc.
Talis Biomedical Corporation
TuSimple Holdings, Inc.
Walgreens Boots Alliance, Inc.
Warner Brothers Discovery, Inc.
Waste Management, Inc.
Wells Fargo & Company
2023 AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp.
AMC Entertainment Holdings, Inc.
Catalent, Inc.
Cornerstone Building Brands, Inc.
Fidelity National Information Services, Inc.
GWG Holdings, Inc.
Hawaiian Electric Industries, Inc.
Masimo Corporation
Mercury Systems, Inc.
Proterra, Inc.
Sea Limited
Spirit AeroSystems Holdings, Inc.
2024 Doximity, Inc.
Equinix, Inc.

 

Appendix 2: Significant Cases Of 2025

Insured Nature of Allegation Class Period
Q1 Micron Technology, Inc. Weak product demand 9/28/23-12/18/24
Block, Inc. Financial platforms failed to conduct KYC checks 2/26/20-4/30/24
Crocs, Inc. False/misleading statement of revenue growth around acquisition 11/3/22-10/28/24
ESSA Pharma Inc. Drug in development was less effective than claimed 12/12/23-10/31/24
Novo Nordisk A/S Obesity study overstated likely weight loss benefit 11/2/22-12/19/24
Telus International Inc. New AI offerings cannibalized existing sales 2/16/23-8/1/24
Target Corporation Marketing touched on culture wars/alienated part of customer base 8/26/22-11/19/24
GSK plc Zantac withdrawal 2/5/20-8/14/22
Elastic N.V. Significant changes to sales operations disrupted sales 5/31/24-8/29/24
Constellation Brands, Inc. Wine & spirit division failed to increase profits 4/11/24-1/8/25
The Trade Desk, Inc. Delayed rollout and faulty execution of AI marketing platform 5/9/24-2/12/25
Atkore Inc. Price fixing of PVC Pipes 2/1/24-2/3/25
Skyworks Solutions, Inc. Semiconductor company misrepresented relationship with Apple 7/30/24-2/5/25
e.l.f. Beauty, Inc. Rising inventory levels due to weak sales 11/1/23-11/19/24
Fluence Energy, Inc. Battery storage company misrepresented relationship with largest customer 11/29/23-2/10/25
Q2 Bakkt Holdings, Inc. Crypto software company dependent on one contract 3/25/24-3/17/25
BigBear.ai Holdings, Inc. Deficient accounting of non-standard transactions 3/31/22-3/25/25
Integrated Wealth Strategies, LLC. Misrepresented risk profile of potential investment 9/22/20-4/17/25
NET Power Inc. Clean energy tech company underestimated cost/time to launch 6/9/23-3/7/25
Avis Budget Group, Inc. Faster fleet rotation shortened useful life of assets/increased depreciation 2/15/24-2/10/25
West Pharmaceutical Services, Inc. Medical supply/packaging company overstated benefits/effectiveness of solutions 02/16/23-02/12/25
Bitfarms Ltd. Data center/miner had deficient internal controls/ misstated financials 03/21/23-12/09/24
Elevance Health, Inc. Health insurer failed to monitor cost trends, and underpriced coverage 04/18/24-10/16/24
Krispy Kreme, Inc. Overstated demand for donuts at McDonalds 2/25/25-5/7/25
DoubleVerify Holdings, Inc. Digital marketing analytics company affected by shift to closed platforms 11/10/23-02/27/25
Tempus Ai, Inc. Medical solutions provider overstated capabilities & strength of relationships 08/06/24-05/27/25
Reddit, Inc. Change to Google’s algorithm affected traffic to site 10/29/24-05/20/25
Apple, Inc. Understated time to integrate SiriAI 06/10/24-06/09/25
Hims & Hers Health, Inc. Telehealth sold fake Wegovy 04/29/25-06/22/25
Petco Health and Wellness Company, Inc. Overstated ability to survive selling premium petfood 1/14/21-6/5/25
Q3 Centene Corp Healthcare company misrepresented enrollment figures 12/12/24-6/30/25
Neogen Corporation Overstated speed/benefits of acquisition/integration 1/5/23-6/3/25
Fiserv, Inc. payment gateway artificially boosted revenue 7/24/24-7/22/25
Lockheed Martin Corporation Failure of internal controls overstated contract profits 1/23/24-7/21/25
Novo Nordisk A/S Overstated growth potential of GLP-1 market 5/7/25-7/28/25
Lineage, Inc. Cold-storage manager IPO didnt disclose weakening demand 7/25/2024
Tesla, Inc. Overstated effectiveness of autonomous driving tech 4/19/23 to 6/22/25
KinderCare Learning Companies, Inc. Education IPO failed to mention cases of child abuse/neglect/harm 10/9/2024
Snap Inc. Overstated ad revenue growth 4/29/25-8/5/25
C3.ai, Inc. Overstated revenue growth, underplayed CEO health concerns 2/26/25-8/8/25
Nutex Health Inc. Alleged fraud on insurance companies and stock compensation accounting issues 8/8/24- 8/14/25
Charter Communications, Inc. Broadband/cable operator understated impact of FCC changes 7/26/24-7/24/25
Dow Inc. Material science company overstated ability to support its dividend 1/30/25-7/23/25
V.F. Corporation Apparel company overstated true state of (Vans) turnaround plan 10/30/23-5/20/25
Fluor Corporation Engineering company failed to disclose rising project costs/slowing economic conditions 2/18/25-7/31/25
Spirit Aviation Holdings, Inc. Overstated financial health/downplayed risk of another Chapter 11 filing 5/28/25-8/29/25
Q4 WPP plc Overstated revenue/growth and understated seasonality 2/27/25-7/8/25
Marex Group Inconsistencies in financial statements, involving subsidiaries and related parties 5/16/24-8/5/25
James Hardie Industries plc Financial statements ignored/denied inventory de-stocking 5/20/25-8/18/25
Synopsys, Inc. Focus on AI impacted margins 12/4/24-9/9/25
CarMax Inc. Overstated growth prospects 6/20/25-9/24/25
Fiserv, Inc. Misled investors about initiatives and projects 7/23/25-10/29/25
Six Flags Entertainment Corporation Merger failed to mention underinvestment 7/1/2024
Freeport-McMoran Inc. Failure to ensure safety at Indonesian mine 2/15/22-9/24/25
Perrigo Company Plc Infant formula business (bought from Nestle) suffered underinvestment 2/27/23 to 11/4/25
StubHub Holdings, Inc. IPO documents failed to mention cashflow impact of payment timing changes 9/17/2025
Sprouts Farmers Market Inc. Understated impact of macroeconomic pressures 6/4/25-10/29/25
Coupang, Inc. Inadequate cybersecurity protocols 8/6/25-12/16/25
SLM Corporation (“Sallie Mae”) Failed to disclose rise in early stage delinquencies 7/25/25-8/14/25
F5, Inc. Failure to disclose security incident 10/28/24-10/27/25
Klarna Group plc Digital bank IPO understated risk of buy now pay later loan delinquency 9/10/2025

TransRe We value risk

TransRe We value risk

TransRe We value risk

  • Home
  • What We Do
  • About Us
  • Contact Us
  • Insights
  • Events
  • Legal
  • Careers
  • PartnersOpens in new window
  • Employees
  • Website Accessibility Statement
  • Opens in new window
    LinkedIn Logo
  • Opens in new window
    Twitter Logo
  • Opens in new window
    Youtube Logo
  • Global Privacy Notice
  • Calpe Insurance Privacy Notice
  • Terms & Conditions

© Transatlantic Reinsurance Company

    To





    (Attachment limit 4MB)

    Click here to read the policy. (PDF)

    The Best’s Company Report(s) reproduced on this site appear under license from A.M. Best and do not constitute, either expressly or implied, an endorsement of (Licensee)’s products or services. A.M. Best is not responsible for transcription errors made in presenting Best’s Company Reports. Best’s Company Reports are copyright © A.M. Best Company and may not be reproduced or distributed without the express written permission of A.M. Best Company. Visitors to this web site are authorized to print a single copy of the Best’s Company Report(s) displayed here for their own personal use. Any other printing, copying or distribution is strictly prohibited.

    Best’s Ratings are under continuous review and subject to change and/or affirmation. To confirm the current rating, please visit the AM Best web site, www.ambest.com.

    See Report